Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Unichem Pharmaceuticals USA Inc.

US Class I Ongoing · initiated 2025-08-27

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90…

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-26

Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-26

Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.

AvKARE

US Class II Ongoing · initiated 2025-08-25

Presence of a foreign substance.

AvKARE

US Class II Ongoing · initiated 2025-08-25

Presence of a foreign substance.

Consumer Product Partners, LLC

US Class III Ongoing · initiated 2025-08-25

Cross Contamination with Other Products.

Consumer Product Partners, LLC

US Class III Ongoing · initiated 2025-08-25

Cross Contamination with Other Products.